These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32218809)

  • 61. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
    Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
    Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.
    Wu Q; You L; Nepovimova E; Heger Z; Wu W; Kuca K; Adam V
    J Hematol Oncol; 2022 Jun; 15(1):77. PubMed ID: 35659268
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.
    Verdeil G; Lawrence T; Schmitt-Verhulst AM; Auphan-Anezin N
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766350
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
    McDonald PC; Chafe SC; Dedhar S
    Front Cell Dev Biol; 2016; 4():27. PubMed ID: 27066484
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NF-κB role on tumor proliferation, migration, invasion and immune escape.
    Khan A; Zhang Y; Ma N; Shi J; Hou Y
    Cancer Gene Ther; 2024 Jul; ():. PubMed ID: 39033218
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD14
    Heeren AM; Kenter GG; Jordanova ES; de Gruijl TD
    Oncoimmunology; 2015 Jun; 4(6):e1009296. PubMed ID: 26155430
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development.
    Grzywa TM; Justyniarska M; Nowis D; Golab J
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669537
    [TBL] [Abstract][Full Text] [Related]  

  • 68. STAT3 activation: A key factor in tumor immunoescape.
    Rébé C; Végran F; Berger H; Ghiringhelli F
    JAKSTAT; 2013 Jan; 2(1):e23010. PubMed ID: 24058791
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Role of Tumor Inflammatory Microenvironment in Lung Cancer.
    Tan Z; Xue H; Sun Y; Zhang C; Song Y; Qi Y
    Front Pharmacol; 2021; 12():688625. PubMed ID: 34079469
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prostate fibroblasts and prostate cancer associated fibroblasts exhibit different metabolic, matrix degradation and PD-L1 expression responses to hypoxia.
    Pacheco-Torres J; Sharma RK; Mironchik Y; Wildes F; Brennen WN; Artemov D; Krishnamachary B; Bhujwalla ZM
    Front Mol Biosci; 2024; 11():1354076. PubMed ID: 38584702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of immune escape in different digestive tumours.
    Du XZ; Wen B; Liu L; Wei YT; Zhao K
    World J Clin Cases; 2021 Dec; 9(34):10438-10450. PubMed ID: 35004976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activating Iterative Revolutions of the Cancer-Immunity Cycle in Hypoxic Tumors with a Smart Nano-Regulator.
    Ding J; Lu Y; Zhao X; Long S; Du J; Sun W; Fan J; Peng X
    Adv Mater; 2024 Jul; 36(29):e2400196. PubMed ID: 38734875
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.
    Steven A; Seliger B
    Breast Care (Basel); 2018 Mar; 13(1):16-21. PubMed ID: 29950962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The roles of curcumin in regulating the tumor immunosuppressive microenvironment.
    Wang Y; Lu J; Jiang B; Guo J
    Oncol Lett; 2020 Apr; 19(4):3059-3070. PubMed ID: 32256807
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor promotion via injury- and death-induced inflammation.
    Kuraishy A; Karin M; Grivennikov SI
    Immunity; 2011 Oct; 35(4):467-77. PubMed ID: 22035839
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Altering the intratumoral localization of macrophages to inhibit cancer progression.
    Casazza A; Mazzone M
    Oncoimmunology; 2014 Jan; 3(1):e27872. PubMed ID: 24800172
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of NF-kB in modulating antitumor immunity.
    Richmond A; Yang J
    Oncoimmunology; 2016; 5(1):e1005522. PubMed ID: 26942050
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
    Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
    Cell Death Differ; 2020 Jul; 27(7):2293. PubMed ID: 32024980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rutin mediated targeting of signaling machinery in cancer cells.
    Perk AA; Shatynska-Mytsyk I; Gerçek YC; Boztaş K; Yazgan M; Fayyaz S; Farooqi AA
    Cancer Cell Int; 2014; 14(1):124. PubMed ID: 25493075
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Author Correction: Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.
    Bruce JP; To KF; Lui VWY; Chung GTY; Chan YY; Tsang CM; Yip KY; Ma BBY; Woo JKS; Hui EP; Mak MKF; Lee SD; Chow C; Velapasamy S; Or YYY; Siu PK; El Ghamrasni S; Prokopec S; Wu M; Kwan JSH; Liu Y; Chan JYK; van Hasselt CA; Young LS; Dawson CW; Paterson IC; Yap LF; Tsao SW; Liu FF; Chan ATC; Pugh TJ; Lo KW
    Nat Commun; 2022 Jul; 13(1):4353. PubMed ID: 35896551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.